Human immunodeficiency virus, commonly known as HIV, is a virus that targets the immune system and can lead to acquired immunodeficiency syndrome (AIDS) if left untreated. HIV can be transmitted through sexual intercourse, using needles that have been in contact with bodily fluids containing HIV, and during pregnancy, childbirth, or breastfeeding—a concept known as vertical transmission.
RESEARCH AREAS
HIV/Aids
Our HIV Studies
- A Prospective Observational Cohort Study on HIV Infection And Risk Related Coinfections/Comorbidities In Indonesia – INA104 (PROACTIVE)
- Dolutegravir and Darunavir Evaluation in adults Failing Therapy (D2EFT)
Tuberculosis
Tuberculosis (TB) is a contagious disease caused by infection with Mycobacterium tuberculosis (Mtb) bacteria. It is spread through the air when a person with TB disease of the lungs or throat coughs, speaks or sings, and people nearby breathe in these bacteria and become infected.
Our TB Studies
- Tuberculosis Research of INA-RESPOND On Drug Resistance – INA102 (TRIPOD)
- Analysis of Host Biomarkers Associated with Adverse TB Treatment Outcomes Across RePORT International Sites
Dengue Fever
Dengue fever is an infectious disease carried by mosquitoes and caused by any of four related dengue viruses. This disease used to be called “break-bone” fever because it sometimes causes severe joint and muscle pain that feels like bones are breaking. Health experts have known about dengue fever for more than 200 years.
Our Dengue Studies
Coronavirus disease (COVID-19)
Coronaviruses are a large family of viruses that usually cause mild to moderate upper-respiratory tract illnesses, like the common cold. However, three coronaviruses have caused more serious and fatal disease in people: SARS coronavirus (SARS-CoV), MERS coronavirus (MERS-CoV), and SARS-CoV-2 (which causes COVID-19).
Our COVID-19 Studies
- INA-RESPOND Observational Research on Infectious Disease Outbreaks & Difficult Cases of Unidentified Etiology in Indonesia; COVID-19 Pandemic – INA107 (ORCHID)
- An International Multicentre, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti Coronavirus Hyperimmune Intravenous lmmunoglobulin for the Treatment of Adult Hospitalized Patients at Onset of Clinical Progression of COVID-19 / Inpatient Treatment with Anti-Coronavirus lmmunoglobulin – ITAC/INSIGHT-013
- International Study on COVID-19 Vaccine to Assess lmmunogenicity, Reactogenicity and Efficacy – InVITE
- An International Observational Study of Outpatients with SARS-CoV- 2 Infection/ International SARS-CoV-2 Infection Observational Study – ICOS
General
General research focuses to identify the etiologies, management, and outcomes of community-acquired.
Our General Studies
- An Observational Study of the Causes, Management, and Outcomes of Community-acquired Sepsis and Severe Sepsis in Southeast Asia – SEA050 (SEPSIS)
- The Etiology of Acute Febrile Illness Requiring Hospitalization – INA101 (AFIRE)
- Implementing a Combination of Clinical Parameters (Rapid Diagnostic Tests (RDTs), Biomarkers, and Standard of Care Procedures (SoCs)) for the Etiology Diagnoses – INA201 (PEER PePPes)
© Copyright - Ina-Respond. 2022